Target intelligence / Profile preview

Diacylglycerol acyltransferase/mycolyltransferase Ag85B (Ag85B) (Ag85B)

Target
Ag85B
Molecular classification
Enzyme, Mycolyltransferase, Acyltransferase
01

Overview

Antigen 85B (Ag85B) is a major secretory protein of Mycobacterium tuberculosis and a key member of the Ag85 complex, which also includes Ag85A and Ag85C. It functions primarily as a mycolyltransferase, an enzyme essential for the biosynthesis of the mycobacterial cell wall by catalyzing the transfer of mycolic acids to the cell wall arabinogalactan and the synthesis of trehalose dimycolate (TDM) (UniProt P9WQP9). In the context of disease, Ag85B is crucial for the structural integrity and virulence of M. tuberculosis, facilitating its survival within host macrophages.

Beyond its enzymatic role, Ag85B acts as a potent immunogen, inducing strong Th1-type immune responses, making it a primary candidate for subunit vaccines against tuberculosis. Therapeutic strategies targeting Ag85B include the development of novel vaccines like H56:IC31 and M72/AS01E, as well as small-molecule inhibitors designed to disrupt cell wall assembly. Because it is highly expressed during the early stages of infection, it serves as a critical target for both preventative and therapeutic interventions.

Other names
FbpBFibronectin-binding protein B30 kDa extracellular proteinalpha-antigenAntigen 85 complex B
02

Mechanism of action

Induction of Th1-mediated immune response via vaccination or inhibition of mycolyltransferase activity to disrupt cell wall synthesis.

03

Biological functions

Cell wall synthesisMycolic acid metabolismImmune responseFibronectin binding
04

Disease associations

Infection
05

Safety considerations

Koch phenomenonInjection site reactionsPotential for immune evasion through sequence variation
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Ag85B-specific IFN-gamma productionAg85B-specific T-cell frequencyAnti-Ag85B IgG antibodies

Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.

Beyond the preview

Go deeper on Diacylglycerol acyltransferase/mycolyltransferase Ag85B (Ag85B) (Ag85B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diacylglycerol acyltransferase/mycolyltransferase Ag85B (Ag85B) (Ag85B).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call